ECUS益卡思品牌怎么样 申请店铺

我要投票 ECUS益卡思在学习桌行业中的票数:282 更新时间:2025-06-03
ECUS益卡思是哪个国家的品牌?「ECUS益卡思」是 深圳益卡思科技发展有限公司 旗下著名品牌。该品牌发源于广东,由创始人徐伟在2010-06-25期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力ECUS益卡思品牌出海!将品牌入驻外推网,定制ECUS益卡思品牌推广信息,可以显著提高ECUS益卡思产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

ECUS益卡思怎么样

1945年Ecus诞生于西班牙MurciaYecla,凭着30多年在医用器械及医用床具领域的研发,成为了世界著名专业从事生产与销售医用器械和医用床具的高端科技睡眠品牌,并得到诸多世界著名医疗机构的推崇。

1978Ecus开始进入生产与销售高科技民用保健床垫的领域,研发出完全适合在孩子不同成长阶段,能有效辅助孩子脊椎健康成长、并能有效抑制驼背的床垫,并随后在欧美47个国家35.56万青少年身上进行了长达16年的使用鉴定,效果斐然。为此,ECUS成为西班牙皇室和西班牙马德里皇家儿童医院唯一指定儿童床垫供应商,并获得国际生态自然基金会颁发的环保证书。Ecus床垫现在已经成为欧洲乃至世界著名的民用高端家具品牌。

1995年Ecus在Yecla修建了西班牙第一个纯粹依靠太阳能发电的床垫生产工厂,并且拥有世界最先进的自动化生产设备,将人工智能最大化应用,真正实现了自动化无人智能流水线作业。

2000年以来Ecus一直高度关注着占全球人口近四分之一的中国,关注着中国2.9亿青少年脊椎的健康成长,在中国经过8年的儿童成长发肓深度调研后,研发出了完全适合在中国孩子不同成长阶段、辅助孩子脊椎健康成长,并能有效抑制驼背的床垫。

2010年Ecus在中国成立益卡思深圳科技发展有限公司,将完全原装西班牙产品引进中国,让中国的青少年儿童同西班牙王子一样享受健康的睡眠。

In 1945, ECUs was born in murciayela, Spain. With more than 30 years of research and development in the field of medical devices and medical beds, it has become a world-famous high-end technology sleep brand specializing in the production and sale of medical devices and medical beds, and has been promoted by many world-famous medical institutions. 1978ecus began to enter the field of production and sales of high-tech civil health mattresses, and developed mattresses that are completely suitable for children's different growth stages, can effectively assist children's healthy growth of spine, and can effectively inhibit hump back. Later, it has been used in 355600 teenagers in 47 countries in Europe and the United States for 16 years, with remarkable results. To this end, ECUs has become the only designated supplier of children's mattresses for the royal family of Spain and the Royal Children's Hospital of Madrid, Spain, and has obtained the environmental protection certificate issued by the international ecological nature foundation. ECUs mattress has become a famous civil high-end furniture brand in Europe and even in the world. In 1995, ECUs built the first mattress production plant in Spain that relies solely on solar power generation in Yecla, and has the most advanced automatic production equipment in the world, which maximizes the application of artificial intelligence and truly realizes the automatic unmanned intelligent assembly line operation. Since 2000, ECUs has been paying close attention to China, which accounts for nearly a quarter of the global population, and the healthy growth of China's 290 million teenagers' spine. After eight years of in-depth research on children's growth and development, it has developed a mattress that is fully suitable for different growth stages of Chinese children and can help their spine grow healthily, and can effectively restrain their humpback. In 2010, ECUs established ICAS Shenzhen Science and Technology Development Co., Ltd. in China, introducing completely original Spanish products to China, so that Chinese teenagers and children can enjoy healthy sleep like the Spanish prince.

本文链接: https://brand.waitui.com/6c56eac4e.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

​5月份公募机构调研侧重硬科技与全球化

公募机构5月份的调研动向侧面揭示了资本市场对“硬科技”与“全球化布局”的关注。公募排排网最新数据显示,5月份共有156家公募机构参与A股上市公司调研,覆盖629只个股,累计调研频次达4791次。其中,半导体、自动化设备等行业成为机构“深挖”的核心方向,企业“出海”战略则成为调研问答中的高频关键词。(证券日报)

刚刚

券商6月“金股”出炉,两大行业含“金”量最高

A股6月开市在即,券商6月月度“金股”近期陆续出炉。Wind数据显示,截至6月2日中国证券报记者发稿时,已有超百只“金股”获得券商推荐,亚钾国际、青岛啤酒、恺英网络等标的关注度较高,部分港股标的也获得券商青睐。从行业分布情况看,前述券商推出的6月月度“金股”较为密集地分布在机械设备、医药生物等行业。就板块投资机会而言,机械设备行业看好可控核聚变产业发展带来的布局机会,医药生物行业建议关注CXO、特色原料药、药房等细分方向。(中证报)

刚刚

消息称马斯克在平价电动汽车项目上出尔反尔,令特斯拉高管无所适从

据知情人士透露,去年特斯拉CEO埃隆·马斯克曾公开否认有关该公司已放弃其2.5万美元电动汽车计划的报道,这让特斯拉的一些高管感到无所适从,因为此前公司内部通讯的确曾经说过该项目将被终止。(新浪财经)

刚刚

中信建投:新消费驱动保健品重估,饮料啤酒等将迎旺季催化

36氪获悉,中信建投研报称,食饮板块第一季度季报仍然保持较高质量,4月份以来总体保持稳定。两会提出要大力提振消费,使内需成为拉动经济增长的主动力和稳定锚,中央发布《提振消费专项行动方案》全方位指引消费复苏。重点看好四个板块,1)白酒。龙头酒企业绩稳健,因时调整引领行业穿越挑战。2)低度酒。啤酒销量反弹,关注旺季改善持续性。3)餐饮链细分龙头多产品渠道布局如海天味业安井食品,景气度环比提升成本端边际改善如安琪酵母涪陵榨菜,受益餐饮连锁化趋势渗透率不断提升如颐海国际等。4)休闲零食保持高景气,新产品和新渠道持续贡献增量,魔芋品类热销,零食品类机遇持续,养生水关注度提升。

1分钟前

创新药板块持续大涨,带动相关ETF水涨船高

近期,创新药尤其是港股创新药板块持续大涨,带动相关ETF水涨船高,并霸屏基金涨幅榜。Wind数据显示,截至5月30日,华泰柏瑞恒生创新药ETF、汇添富港股通创新药ETF、银华港股创新药ETF年内分别上涨42.84%、42.56%、41.88%,位居今年ETF涨幅榜前三。此外,万家港股创新药ETF、广发港股创新药ETF的年内涨幅也超过了40%。(证券时报)

2分钟前

本页详细列出关于ECUS益卡思的品牌信息,含品牌所属公司介绍,ECUS益卡思所处行业的品牌地位及优势。
咨询